For citations:
Shesternya PA, Zagrebneva AI, Antipova OV, Arbuzova YV, Bannikova IG, Belozertseva LV, Bogdanova EA, Bykova SA, Vasilenko EA, Vinogradova IB, Davidyan SY, Epifanova OE, Zemerova EV, Zlobin MV, Ivanova LV, Ilyina NA, Ilyushina LV, Klyuchnikova EP, Makevnina AV, Myasoutova ER, Nakonechnaya EE, Pavlova AB, Plaksina TV, Rybin AV, Salnikova TS, Solodovnikova LV, Fedorova AV, Cherencova IA, Jakovleva EV, Yakupova SP, Alekseev EN, Lila AM. Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(2):39-49. https://doi.org/10.14412/1996-7012-2025-2-39-49